Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine blood-stage Plasmodium falciparum challenge study in healthy adults
ACTRN12612000323820Phase 2Completed
- Sponsor
- QIMR Berghofer Medical Research Institute
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of mefloquine in malaria (3 cohorts), sponsored by QIMR Berghofer Medical Research Institute. Primary endpoint: Pharmacokinetic-pharmacodynamic relationship of mefloquine on parasite clearance. Started Apr 2012; status: completed.
02
Drugs
mefloquine
03
Conditions
malaria
Beyond the preview
Go deeper on ACTRN12612000323820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000323820.